Found 7 matching trials
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma PHASE2 The purpose of this study is to evaluate how safe and effective the combina...
Show More Learn More & Join Trial
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer PHASE1 A multi-center, open-label phase I/II study to to determine the safety and ...
Show More Learn More & Join Trial
An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study) PHASE1 The study hypothesis is that lenalidomide and romidepsin (and dexamethasone...
Show More Location
Yale Cancer Center
Learn More & Join Trial
Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas PHASE1 This is an open label phase Ib/IIa study of patients with relapsed/refracto...
Show More Location
University of Nebraska Medical Center
Learn More & Join Trial
Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma PHASE1 This phase I/II trial studies the side effects and best dose of romidepsin ...
Show More Location
Multiple Locations
Learn More & Join Trial
Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma PHASE1 The treatments used to treat lymphoma and multiple myeloma sometimes do not...
Show More Location
Saint Francis/Mount Sinai Regional Cancer Center
Learn More & Join Trial
Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies PHASE1 Background:
Mature T-cell malignancies (TCMs) are a rare group of cancers ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial